Role for botulinum toxin in back pain treatment in adults with cerebral palsy: Report of a case

Joint Bone Spine

Volumn 71, Issue 1, 2004, Pages 76-78

  Gallien, Philippe ^a   Nicolas, Benoît ^a,b   Petrilli, Sabine ^a   Kerdoncuff, Valérie ^a   Lassalles, Arnaud ^a   Le Tallec, Hélène ^a   Durufle, Aurélie ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b Clinique Notre Dame de Lourdes   (France)

Author keywords

Botulinum toxin A; Cerebral palsy; Dystonia; Low back pain

Indexed keywords

BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; CENTRAL MUSCLE RELAXANT; DANTROLENE; TETRAZEPAM;

ADULT; ARTICLE; BACK MUSCLE; BACKACHE; BODY POSTURE; CASE REPORT; CEREBRAL PALSY; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG EFFECT; DRUG RESPONSE; DYSTONIA; FEMALE; HUMAN; LABORATORY TEST; LORDOSIS; LOW BACK PAIN; MUSCLE HYPOTONIA; MUSCLE SPASM; NEUROLOGIC DISEASE; PHYSICAL EXAMINATION; SITTING; TREATMENT OUTCOME;

EID: 0842288712     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(03)00124-6     Document Type: Article

References (20)

1. Madigan R.R., Wallace S.L. Scoliosis in the institutionalized cerebral palsy population. Spine. 6:1981;583-590.
2. Anderson W.W., Wise B.L., Itabashi H.H., Jones M. Cervical spondylosis in patients with athetosis. Neurology. 12:1962;410-412.
3. Majd M.E., Muldowny D.S., Holt R.T. Natural history of scoliosis in the institutionalized adult cerebral palsy population. Spine. 22:1997;1461-1466.
4. Nicolas B., Gallien P., Robineau S., de Crouy A.C., Fernandez R. Consultation d'IMC adultes: l'expérience rennaise. Ann Réad Med Phys. 43:2000;344.
5. Calderon-Gonzales R., Calderon-Sepulveda R.F., Rinconreyes M., Garciaramirez J., Minorango E. Botulinum toxin A in management of cerebral palsy. Pediat Neurol. 10:1994;284-288.
6. Edgar T.S. Clinical utility of botulinum toxin in the treatment of cerebral palsy: comprehensive review. J Child Neurol. 16:2001;37-46.
7. Kirsschner J., Berweck S., Mall V., Korinthenberg R., Heinen F. Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option. J Neurol. 248:(Suppl 1):2001;28-30.
8. Comella C.L., Schannon K.M., Jaglin J. Extensor truncal dystonia: successful treatment with botulinum toxin injections. Mov Disord. 13:1998;552-555.
9. Davis D., Jabbari B. Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A. Mov Disord. 8:1993;371-373.
10. Foster L., Clapp L., Erikson M., Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology. 56:2001;1290-1293.
11. Saito N., Ebara S., Ohotsuka K., Kumeta H., Takaoka K. Natural history of scoliosis in spastic cerebral palsy. Lancet. 351:1998;1687-1692.
12. Basciani M., Intisito D., Cioffi R.P., Tonali P. Preoperative treatment with botulinum A toxin in patients with cervical disk herniation secondary to dystonic cerebral palsy. Neurol Sci. 21:2000;63.
13. Mikawa Y., Watanabe R., Shikata J. Cervical myelo-radiculopathy in athetoid cerebral palsy. Arch Orthop Trauma Surg. 116:1997;116-118.
14. Onari K. Surgical treatment for cervical spondylotic myelopathy associated with athetoid cerebral palsy. J Orthop Sci. 5:2000;439-448.
15. Harada T., Ebara S., Anwar M.M., Kajiura I., Oshita S., Hiroshima K., et al. The lumbar spine in spastic diplegia. A radiographic study. J Bone Joint Surg Br. 75:1993;534-537.
16. Ravitz E., Moore M.E., Glaros A. Paralumbar muscle activity in chronic low back pain. Arch Phys Med Rehabil. 62:1981;172-176.
17. Lazorthes Y., Sallerin B., Verdie J.C., Casaux J., Caraoué F., Sol J.C. Traitement de la spasticité par administration intra-thécale chronique de baclofène. Neurochir. 44:1998;201-208.
18. Adler C.H., Zimmerman R.S., Lyons M.K., Simeone F., Brin M.F. Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease. Mov Disord. 11:1996;79-81.
19. Gallien P., Durufle A., Petrilli S., Verin M., Brissot R., Robineau S. Atypical low back pain: stiff-person syndrome. J Bone Spine. 69:2002;218-221.
20. Jankovic J., Schwartz K. Response and immuno-resistance to botulinum injections. Neurology. 45:1995;1743-1746.